Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-5-HTP PET for Beta Cell Mass in Islet Transplant
NCT02689479Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 11C-5-hydroxytryptophan in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Relationship between beta cell mass calculated from 11C-5-HTP PET scans and MMTT C-peptide at 90 minutes. Started May 2013; status: completed.
02
Drugs
11C-5-hydroxytryptophan
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02689479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689479.